HomeHealth

Health

Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced Chromosomal Rearrangements Found in Recurrent Pregnancy Loss

Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced Chromosomal Rearrangements Found in Recurrent Pregnancy Loss

September 21, 2022

Astellas and MBC BioLabs Announce Astellas Future Innovator Prize to Help Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts

Astellas and MBC BioLabs Announce Astellas Future Innovator Prize to Help Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts

September 20, 2022

Inventor of the Year Awarded to Developer of Phexxi®

Inventor of the Year Awarded to Developer of Phexxi®

September 20, 2022

Illumina to Host Upcoming Investor Day

Illumina to Host Upcoming Investor Day

September 20, 2022

McKesson Signs Agreement to Acquire Rx Savings Solutions

McKesson Signs Agreement to Acquire Rx Savings Solutions

September 20, 2022

PHILIPS SONICARE ANNOUNCES MARSAI MARTIN AS FIRST EVER COME BACK COACH

PHILIPS SONICARE ANNOUNCES MARSAI MARTIN AS FIRST EVER COME BACK COACH

September 20, 2022

Zimmer Biomet Receives FDA Clearance for Identity(TM) Shoulder System for Shoulder Replacement

Zimmer Biomet Receives FDA Clearance for Identity(TM) Shoulder System for Shoulder Replacement

September 20, 2022

Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care

Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care

September 20, 2022

AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderate to Severe Crohn’s Disease

AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderate to Severe Crohn’s Disease

September 19, 2022

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL(TM) Cerebral Protection System

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL(TM) Cerebral Protection System

September 18, 2022

« 1 … 98 99 100 101 102 … 123 »